What's Driving the Gastrointestinal infection testing market Growth ? Prominent Players - BD, and Company (BD), Thermo Fisher Scientific, Bio-Rad Laboratories, Luminex Corporation, Roche, Illumina, SEEGENE INC., SEEGENE

The global gastrointestinal infection testing market has been segmented by disease strains, product type and end user. The gastrointestinal infection testing market has been segmented by disease strains into bacterial strains, viral strains and parasitic strains. Based on product type, the gastrointestinal infection testing market is segmented into reagent kits, sequencing kits and equipment. In terms of revenue, the reagent kits segment is expected to hold major share during the forecast period due to its user-friendly nature and accurate detection of foreign agents. On the basis of end users, the gastrointestinal infection testing market is segmented into hospitals, clinics/medical centers, diagnostic laboratories and research institutes. The hospital segment is expected to show high revenue growth as an increasing number of people are getting hospitalized due to increasing gastrointestinal infections.

Get Sample Copy of This Report@ https://www.persistencemarketresearch.com/samples/17314

The report tracks some of the key companies operating in the gastrointestinal infection testing market, such as Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Luminex Corporation, Hoffmann-La Roche Ltd., bioMérieux SA, Quidel Corporation, Illumina, Inc., Seegene Inc and Genetic Signatures.

Gastrointestinal (GI) infections are one of the most common infections in primary care. According to NCBI (National Center for Biotechnology Information), around 200 Mn GI infections occur in the U.S. annually. To detect bacteria, virus and parasites, gastrointestinal infection testing is done. The molecu-lar tool is used for fast discovery of bacteria in clinical specimens and allows early and clear laboratory validation of related diseases. Since the past few years, real-time PCR tests have been widely devel-oped in clinical microbiology labs for routine gastrointestinal infection testing of infectious diseases, such as bacterial, viral and parasitic diseases. This factor will boost the growth of the gastrointestinal infection testing market during the forecast period. According to the latest report published by the company, the global gastrointestinal infection testing market is projected to account for over US$ 490.2 Mn, in terms of value, by 2026 end. The report further projects that the gastrointestinal infection testing market will grow at a CAGR of 5.1% through 2026.

Growing Usage of Sophisticated Infection Detection Panels and Infectious Testing Kits to Give a Boost to the Gastrointestinal Infection Testing Market
Diarrhea is one of the leading causes of deaths. According to WHO, diarrhea kills around 525 Mn chil-dren aged 5 years or less every year. Gastrointestinal infection testing is done using PCR systems that provide a quick valuation of gene mutations or the presence of antibiotic resistance genes. This factor will increase the growth of the gastrointestinal infection testing market during the forecast period. That apart, increasing healthcare expenditure by governments has enabled the usage of sophisticated infection detection panels and infectious testing kits in hospitals, diagnostic laboratories and institutes. This factor, in particular, is likely to play an instrumental role in driving the growth of the gastrointestinal infection testing market during the forecast period.

Request For Methodology @ https://www.persistencemarketresearch.com/methodology/17314

Stringent rules and regulations set by the U.S. Food and Drug Administration (FDA) may hinder the growth of the gastrointestinal infection testing market. The North America gastrointestinal infection testing market is expected to give a boost to the growth of the gastrointestinal infection testing market due to increasing healthcare spending and government initiatives to spread awareness and availability of better gastrointestinal infection testing options in the region. The Asia Pacific ex. China gastrointestinal infection testing market is expected to grow at highest CAGR owing to increasing patient pool due to unhygienic lifestyle and improper sanitation facilities in this region. The Asia Pacific ex. China gastrointestinal infection testing market is estimated to create incremental $ opportunity worth US$ 41.9 Mn between 2018 and 2026.

4. Market Background
4.1. Gastrointestinal Infection Outlook
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.3. Key Trends

5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2006 – 2021
5.2. Healthcare Spending Outlook

6. Key Inclusion
6.1. Disease Epidemiology/Statistics
6.2. Regulatory Scenario
6.3. Pricing Analysis and Forecast

7. Global Gastrointestinal Infection Testing Market Analysis 2013–2017 and Forecast 2018–2026, By Region
7.1. Introduction/Key Findings
7.2. Historical Market Size (US$ Mn) Trend Analysis by Region, 2013–2017
7.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
7.3.1. North America
7.3.2. Latin America

7.3.3. Europe
7.3.4. Asia Pacific Excluding China
7.3.5. China
7.3.6. Middle East & Africa

8. Global Gastrointestinal Infection Testing Analysis 2013–2017 and Forecast 2018–2026, By Disease Strains, By Product, and By End User
8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains, 2013–2017
8.2.1. Bacterial Strain
8.2.1.1. Clostridium difficile

8.2.1.2. E. coli
8.2.1.3. Salmonella
8.2.1.4. Staphylococcus aureus
8.2.1.5. Campylobacter
8.2.1.6. Other Bacterial Strains
8.2.2. Viral Strains

8.2.2.1. Adenovirus
8.2.2.2. Enterovirus
8.2.2.3. Norovirus
8.2.2.4. Rotavirus
8.2.2.5. Sapovirus
8.2.2.6. Other Viral Strains
8.2.3. Parasitic Strains
8.2.3.1. Cryptosporidium parvum
8.2.3.2. Giardia lamblia

8.2.3.3. Other Parasitic Strains
8.3. Market Size (US$ Mn) Forecast By Product, 2018–2026
8.4. Market Attractiveness Analysis by Disease Strains Type
8.5. Historical Market Size (US$ Mn) Trend Analysis by Product Type, 2013–2017
8.5.1 Reagent Kits
8.5.1.1. PCR Detection Panels
8.5.1.1.1. Norovirus Detection Panels
8.5.1.1.2. Rotavirus Detection Panels

8.5.1.1.3. Adenovirus Detection Panels
8.5.1.1.4. Sapovirus Detection Panels
8.5.1.1.5. Other Viral Detection Panels
8.5.1.1.6. Parasitic Detection Panels
8.5.1.1.7. Clostridium difficile Detection Panels
8.5.1.1.8. Other Detection Panels
8.5.2. Sequencing Kits
8.5.3. Equipment

8.5.3.1. Automated PCR Systems
8.5.3.2. Sequencers
8.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2026
8.7. Market Attractiveness Analysis by Product Type
8.8. Historical Market Size (US$ Mn) Trend Analysis by End User Type, 2013–2017
8.8.1. Hospitals
8.8.2. Clinics/Medical Centers

8.8.3. Diagnostic Laboratories
8.8.4. Research Institutes
8.9. Market Size (US$ Mn) Forecast By End User Type, 2018–2026
8.10. Market Attractiveness Analysis by Product Type
8.11. Y-o-Y Growth Analysis by Disease Strains, by Product, and by End User

Full Report@ https://www.persistencemarketresearch.com/market-research/gastrointestinal-infection-testing-market.asp

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.